Monoclonal antibodies lead biosimilar approvals because of their large market size, well-defined regulatory pathways, and ...

SUZHOU, China I March 23, 2025 I CStone Pharmaceuticals ("CStone", HKEX: 2616), a biopharmaceutical company dedicated to developing innovative cancer ...

Biosimilars are essential healthcare equalizers, but their regulation is overly complicated due to lobbying by makers of ...

AI-powered digital pathology specialist PathAI, based in Boston in the US, said that AIM-NASH AI Assist is designed to assist ...

Mumbai-based Kilitch Drugs Ltd plans to enter biosimilars and oral solids, including diabetic and weight-loss tablets, and is ...

Global biosimilar regulatory harmonization will be needed to reduce development costs and improve patient access, despite ...

The global leukemia therapeutics treatment market is expected to grow at a CAGR of 6.6% during the forecast period (2025–2035). Factors such as the rising prevalence of leukemia, increasing adoption ...

Regeneron Pharmaceuticals, Inc. faces Eylea revenue decline but shows growth potential with Dupixent & Libtayo. Click for ...

At its March meeting, the European Medicines Agency’s management board adopted the EMA’s annual report for 2024. This ...

DelveInsight's "BAVENCIO Market Size, Forecast, and Market Insight Report" highlights the details around BAVENCIO, a human ...

“Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of Biocon ... within the equivalence limits set by the U.S. FDA and EMA. Additionally, YESINTEK's safety ...